Advances in biodesign: artificial water channels outperforming aquaporins.

Kidney Int

Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium; Institute of Physiology, University of Zurich, Zurich, Switzerland. Electronic address:

Published: April 2023

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2023.01.015DOI Listing

Publication Analysis

Top Keywords

advances biodesign
4
biodesign artificial
4
artificial water
4
water channels
4
channels outperforming
4
outperforming aquaporins
4
advances
1
artificial
1
water
1
channels
1

Similar Publications

protein design has advanced such that many peptide assemblies and protein structures can be generated predictably and quickly. The drive now is to bring functions to these structures, for example, small-molecule binding and catalysis. The formidable challenge of binding and orienting multiple small molecules to direct chemistry is particularly important for paving the way to new functionalities.

View Article and Find Full Text PDF

Cellular forces regulate an untold spectrum of living processes, such as cell migration, gene expression, and ion conduction. However, a quantitative description of mechanical control remains elusive due to the lack of general, live-cell tools to measure discrete forces between biomolecules. Here we introduce a computational pipeline for force measurement that leverages well-defined, tunable release of a mechanically activated small molecule fluorophore.

View Article and Find Full Text PDF

Novel Computational and Artificial Intelligence Models in Cancer Research.

Cancers (Basel)

January 2025

Center for Precision Health, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

The ICIBM 2023 marked the 11th annual conference of its kind, with the ICIBM recently becoming the official conference of the International Association for Intelligent Biology and Medicine (IAIBM), showcasing cutting-edge advancements at the intersection of computation and biomedical research [...

View Article and Find Full Text PDF

Biofunctionalisation of porous additively manufactured magnesium-based alloys for Orthopaedic applications: A review.

Biomater Adv

January 2025

School of Mechanical and Manufacturing Engineering, Dublin City University, D09 NA55 Dublin, Ireland; Centre for Medical Engineering Research, Dublin City University, D09 NA55 Dublin, Ireland; Advanced Manufacturing Research Centre (I-Form), School of Mechanical and Manufacturing Engineering, Dublin City University, D09 NA55 Dublin, Ireland; School of Pharmacy, Queen's University Belfast, 97 Lisburn Rd, Belfast BT9 7BL, United Kingdom; Biodesign Europe, Dublin City University, D09 NA55 Dublin, Ireland; Tissue, Engineering Research Group, Department of Anatomy and Regenerative Medicine, Royal College of Surgeons in Ireland, D02 PN40 Dublin, Ireland; Advanced Processing Technology Research Centre, Dublin City University, D09 NA55 Dublin, Ireland; Trinity Centre for Biomedical Engineering, Trinity Biomedical Sciences Institute, Trinity College Dublin, D02 PN40 Dublin, Ireland; Advanced Materials and Bioengineering Research Centre (AMBER), Trinity College Dublin, D02 PN40 Dublin, Ireland; Department of Mechanical and Manufacturing Engineering, School of Engineering, Trinity College Dublin, D02 PN40 Dublin, Ireland. Electronic address:

Magnesium (Mg) alloys have gained significant attention as a desirable choice of biodegradable implant for use in bone repair applications, largely owing to their unique material properties. More recently, Mg and Mg-based alloys have been used as load-bearing metallic scaffolds for bone tissue engineering applications, offering promising opportunities in the field. The mechanical properties and relative density of Mg-based alloys closely approximate those of natural human bone tissue, thereby mitigating the risk of stress-shielding effects.

View Article and Find Full Text PDF

Congenital heart defects (CHDs) are the most common congenital defect, occurring in approximately 1 in 100 live births and being a leading cause of perinatal morbidity and mortality. Of note, approximately 25% of these defects are classified as critical, requiring immediate postnatal care by pediatric cardiology and neonatal cardiac surgery teams. Consequently, early and accurate diagnosis of CHD is key to proper prenatal and postnatal monitoring in a tertiary care setting.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!